Mutual fund holdings in Ennature Bio Pharma Limited: who holds it and who bought and sold in Sep 2026, with its other institutional holdings, each beside the price.
In Sep 2026, 1 fund house bought ENNATURE (1 new) and 0 sold, of the 45 houses with portfolios for both Aug 2026 and Sep 2026; index and arbitrage funds left out.
Their net buying was 27,756 shares, ₹3.7 cr at the Sep 2026 month-end price.
Largest buyer WhiteOak Capital Mutual Fund, +27,756 shares.
In Sep 2026, 1 fund house held Ennature Bio Pharma (ENNATURE) through 6 schemes, together 0.21% of its equity. Largest holdings by shares: WhiteOak Capital Special Opportunities Fund, Motilal Oswal Nifty Microcap 250 Index Fund, Groww Nifty Total Market Index Fund. Funds holding Ennature Bio Pharma, Sep 2026
What it is. Shares of this company held by mutual funds, taken from the portfolio each fund house publishes for every month end. Some index-only schemes publish only every quarter. "Houses" counts the fund houses holding it in an active scheme.
How to read it. "% of equity" is the shares funds hold divided by all the company's shares. A change between two months compares only the houses with a portfolio in both months. Share counts move when funds add to or cut a holding, or when a split or bonus is applied.
Does not show: Trades inside the month, or why a fund changed its holding.
In Sep 2026, compared with Aug 2026: 0 schemes bought, 0 sold, 1 new, 0 exited; net +₹3.7 cr at the Sep 2026 month-end price.
Fund houses holding, bought and sold count active schemes only. Index and arbitrage funds are left out. MF holding counts every scheme.
How many fund houses hold it in an active scheme, and how many bought more, cut, entered or left this month. More houses adding than cutting is broad buying, not one fund's bet.
holding in an active scheme · 45 houses with both months
Largest buyer WhiteOak Capital Mutual Fund, +27,756 shares.
The teal line is the shares all mutual funds held at each month end; the faint line is the month-end price. Teal rising while the faint line falls means funds bought as the price dropped.
Price implied from fund-house portfolio files (market value ÷ quantity), not an exchange price. % change over 1, 3, 6, 12 months
| Scheme fund house | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|
| WhiteOak Capital Special Opportunities Fund WhiteOak Capital Mutual Fund | — | 27,756 | ▲ +27,756 |
| Scheme fund house | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|
| No active scheme in this bucket for Sep 2026. | |||
| Scheme fund house | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|
| No active scheme in this bucket for Sep 2026. | |||
| Scheme fund house | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|
| No active scheme in this bucket for Sep 2026. | |||
All fund houses and every scheme holding ENNATURE → Shares as disclosed, split or bonus adjusted.
| Fund house | Aug 2026 | Sep 2026 | Change | % of equity | Activity |
|---|---|---|---|---|---|
| WhiteOak Capital Mutual Fund | — | 27,756 | ▲ +27,756 | 0.12% | New |
Delayed quote ₹251.70, via Yahoo, last trade 4 Nov 2026, 3:29 PM IST, read after the 3:30 PM IST close. A different source from the NSE close: not on the chart, not in the % above.
| Fund house | Current streak | First entered |
|---|---|---|
| WhiteOak Capital Mutual Fund | 1 month added | Sep 2026 |
Since Oct 2025: an entry or exit needs a stored month before it to compare with. Earlier entries and exits are not shown until older portfolios are added.
| Month | Houses that entered | Houses that exited |
|---|---|---|
| Sep 2026 | WhiteOak Capital Mutual Fund | – |
Streak = consecutive stored months the house's active-scheme holding moved the same way (up or down); a flat or not-compared month breaks it, it does not carry over. First entered = the earliest stored month its active holding went above zero; "held when first read" = it already held the stock in the first month this site has the house's portfolio, so that month is not an entry.
Entered = the house's active-scheme holding went from none to some that month; exited = from some to none. A house read for the first time, or after a missing month, is not counted as entering: it may have held the stock before.
| Month end | Houses holding (active funds) | Fund houses with a portfolio | Schemes holding (index funds too) | Holders with no portfolio that month |
|---|---|---|---|---|
| Sep 2026 | 1 | 45 | 6 | 0 |
| Aug 2026 | 0 | 45 | 0 | 0 |
| Jul 2026 | 0 | 45 | 0 | 0 |
| Jun 2026 | 0 | 43 | 0 | 0 |
| May 2026 | 0 | 45 | 0 | 0 |
| Apr 2026 | 0 | 44 | 0 | 0 |
| Mar 2026 | 0 | 43 | 0 | 0 |
| Feb 2026 | 0 | 43 | 0 | 0 |
| Jan 2026 | 0 | 43 | 0 | 0 |
| Dec 2025 | 0 | 44 | 0 | 0 |
| Nov 2025 | 0 | 43 | 0 | 0 |
| Oct 2025 | 0 | 43 | 0 | 0 |
Fund houses holding it in an active scheme, of those with a portfolio for that month. How to read this table
| Over | Since | MF shares held | Implied price |
|---|---|---|---|
| 3 months | Jun 2026 | — | — |
| 6 months | Mar 2026 | — | — |
| 12 months | Sep 2025 | — | — |
| Month | MF shares held | % of equity | Implied price | Houses agreeing |
|---|---|---|---|---|
| Oct 2025 | — | — | — | — |
| Nov 2025 | — | — | — | — |
| Dec 2025 | — | — | — | — |
| Jan 2026 | — | — | — | — |
| Feb 2026 | — | — | — | — |
| Mar 2026 | — | — | — | — |
| Apr 2026 | — | — | — | — |
| May 2026 | — | — | — | — |
| Jun 2026 | — | — | — | — |
| Jul 2026 | — | — | — | — |
| Aug 2026 | — | — | — | — |
| Sep 2026 | 47,381 | 0.21% | ₹1,330.05 | 5 of 5 |
Month-end price implied from fund-house portfolio files (market value ÷ quantity), the median across fund houses; not an exchange price. How it is worked out
What it is. Exchange lists that restrict trading in a stock: the F&O ban (no fresh F&O positions), and the Additional and Graded Surveillance Measures (ASM and GSM), which tighten trading conditions with steps such as higher margins, narrower price bands and trade-for-trade settlement.
How to read it. The card shows whether the stock is on a list today, from the exchange's daily files.
Does not show: Anything about the company beyond being listed.
The exchange's own lists: F&O ban and surveillance. They say the stock is on a list, not why it moved.
Ennature Bio Pharma has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed Ennature Bio Pharma under no ASM or GSM stage on 4 Nov 2026. Pledge invocations are not available yet.
Nothing to show for Ennature Bio Pharma in the period checked Named FPIs at 1% or more: No shareholding pattern for Ennature Bio Pharma has been collected yet. · Promoter pledge: No shareholding pattern for Ennature Bio Pharma has been collected yet. · Delivery: NSE prints no delivery % for Ennature Bio Pharma: it trades in the BE series, where every trade settles by delivery. · Bulk and block deals: No bulk or block deals in Ennature Bio Pharma from 7 Aug 2026 to 4 Nov 2026. · Insider and promoter: No insider or promoter trade in Ennature Bio Pharma dated 7 Aug 2026 to 4 Nov 2026 was disclosed. · MTF book: NSE listed no margin trading position for Ennature Bio Pharma on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026. · SLBM borrowing: NSE listed no securities-lending (SLB) open position for Ennature Bio Pharma on any of the 56 days collected, 14 Aug 2026 to 4 Nov 2026. No SLBM trades in Ennature Bio Pharma on 4 Nov 2026.
Quote ↗ · Insider trades ↗ · Shareholding pattern ↗ · Corporate announcements ↗ · Bulk and block deals ↗
AMC monthly portfolios (SEBI disclosure) · Yahoo Finance (delayed quote) · NSE shareholding pattern filings (XBRL), quarterly · NSE security-wise delivery, daily · NSE bulk and block deals, daily · NSE insider trading disclosures (SEBI PIT, XBRL) · NSE F&O ban list, market-wide position limits and surveillance indicators, daily · NSE margin trading disclosure, daily · NSE securities lending and borrowing (SLBS, SLBM), daily. Each card and table shows its own date.
Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.
